In moderate COVID-19 cases, bronchoalveolar macrophage-epithelial interactions promote an increase in IL-6 and a decrease in the counts of total T-cells, particularly CD4+ and CD8+ T-cells. The gene discussed is CD4; the disease is COVID-19.